(Q34486318)

2 August 2017

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome (English)

1 reference

2 August 2017

0 references

0 references

1 reference

Müller-Vahl KR

1

1 reference

2 August 2017

Kolbe H

series ordinal

2

1 reference

2 August 2017

Schneider U

series ordinal

3

1 reference

2 August 2017

Emrich HM

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

Acta Psychiatrica Scandinavica

2 August 2017

1 reference

2 August 2017

98

1 reference

2 August 2017

502-506

1 reference

2 August 2017

6

1 reference

Effective treatment of Tourette's syndrome with marijuana.

2 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

Tetrahydrocannabinol for tremor in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

The cannabinoid receptor: biochemical, anatomical and behavioral characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1998.TB10127.X

10.1111/J.1600-0447.1998.TB10127.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference